Search
Migraine Clinical Trials in Rochester, MN
A listing of 3 Migraine clinical trials in Rochester, MN actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1 - 3 of 3
The city of Rochester, Minnesota, currently has 3 active clinical trials seeking participants for Migraine research studies.
Featured Trial
Migraine Clinical Study
Recruiting
A clinical study for people that suffer with Migraine
Conditions:
Migraine
Featured Trial
Healthy Participants Needed (Colonoscopy + Cancer Screening)
Recruiting
Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
Conditions:
Healthy
Healthy Volunteers
Healthy Subjects
Healthy Volunteer
Healthy Participants
Featured Offer
Ketamine Therapy—At Home, Clinician-Guided (Innerwell)
If you’re exploring options besides a clinical trial, Innerwell provides at-home ketamine therapy with medical oversight and structured support. Ketamine-assisted treatment may help “reset” rigid stress and mood patterns, and some people feel relief within a few sessions. Your care team works with you to tailor treatment and track progress every step of the way. Proven effective for Anxiety, PTSD, Depression, Addiction, and other disease areas.
Conditions:
Anxiety
Anxiety Disorders
Generalized Anxiety Disorder
Depression
Depression
Featured Trial
Chronic Kidney Disease Clinical Study
Recruiting
We are seeking individuals of African descent interested in a clinical study investigating an investigational treatment for chronic kidney disease caused by genetic factors that primarily affect people of African descent, specifically focusing on APOL-1 mediated kidney disease.
Conditions:
Chronic Kidney Disease
Chronic Kidney Diseases
Chronic Kidney Failure
Chronic Kidney Disease (CKD)
Chronic Kidney Disease(CKD)
Featured Trial
Buy Retatrutide Online Through Celia
Recruiting
Retatrutide (formerly M25) is an investigational peptide being studied for its potential in supporting weight management and metabolic health. It acts on GLP-1, GIP, and glucagon receptors to influence appetite, energy regulation, and fat metabolism.
Conditions:
Healthy
Featured Trial
COVID Vaccine (Age 50-64) Clinical Study
Recruiting
A clinical study for people that suffer with COVID Vaccine (Age 50-64)
Conditions:
COVID Vaccine (Age 50-64)
Healthy
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
Recruiting
This goal of this study is to compare three medications used for migraine preventive treatment.
This study will compare atogepant, a newer migraine preventive medication, with two older preventive medications, topiramate and propranolol. It will be determined if one works better and is more tolerable than the others.
Research participants will:
* Be randomly assigned to one of the three medications.
* Provide information about their migraine pattern using a daily headache diary and during res... Read More
Gender:
ALL
Ages:
Between 18 years and 70 years
Trial Updated:
08/06/2025
Locations: Mayo Clinic, Rochester, Minnesota
Conditions: Migraine
Efficacy of Nerve Blocks for Episodic Migraine
Recruiting
The purpose of this study is to see how well blocking two to ten of the scalp nerves (that give feeling to the scalp and are painful during migraine headaches) with bupivacaine anesthetic (numbing medication) and low dose methylprednisolone (cortisone-like medicine or steroid) work for treating and preventing migraines. Our hypothesis is that the pain of most episodic migraine headaches can be eliminated and prevented for months by blocking the nerves that give pain sensation during a migraine.
Gender:
ALL
Ages:
Between 18 years and 64 years
Trial Updated:
03/21/2025
Locations: Mayo Clinic in Rochester, Rochester, Minnesota
Conditions: Episodic Migraine
A PIVOTAL STUDY EVALUATING SAFETY and EFFICACY of the SHIRATRONICS MIGRAINE THERAPY SYSTEM
Recruiting
Prospective, multi-center, double blind, randomized, sham-controlled study to evaluate neuromodulation in patient with chronic migraine. The study hypothesis to be tested is the mean reduction in mean monthly headache days between patients in treatment versus sham.
Gender:
ALL
Ages:
22 years and above
Trial Updated:
03/04/2025
Locations: Mayo Clinic Rochester, Rochester, Minnesota
Conditions: Headache Migraine Chronic
1 - 3 of 3
